These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10987198)

  • 21. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats.
    Işeri SO; Sener G; Saglam B; Ercan F; Gedik N; Yeğen BC
    Regul Pept; 2008 Feb; 146(1-3):73-9. PubMed ID: 17884193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The thalidomide analog 3-phthalimido-3-(3,4-dimethoxyphenyl)-propanoic acid improves the biliary cirrhosis in the rat.
    Fernández-Martínez E; Pérez-Hernández N; Muriel P; Pérez-Alvarez V; Shibayama M; Tsutsumi V
    Exp Toxicol Pathol; 2009 Sep; 61(5):471-9. PubMed ID: 19095429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells.
    Rockey DC; Fouassier L; Chung JJ; Carayon A; Vallee P; Rey C; Housset C
    Hepatology; 1998 Feb; 27(2):472-80. PubMed ID: 9462646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary biliary cirrhosis in the rat is prevented by decreasing NF-κB nuclear translocation and TGF-β expression using allopurinol, an inhibitor of xanthine oxidase.
    Aldaba-Muruato LR; Moreno MG; Hernández-Mercado E; Shibayama M; Muriel P
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1469-78. PubMed ID: 23181275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivo.
    Pfab T; Stoltenburg-Didinger G; Trautner C; Godes M; Bauer C; Hocher B
    Br J Pharmacol; 2004 Jan; 141(2):215-22. PubMed ID: 14662722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin regulates endothelin-B receptor in rat inner medullary collecting duct.
    Wong NL; Tsui JK
    Metabolism; 2001 Jun; 50(6):661-6. PubMed ID: 11398142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differential expression of protease-activated receptor 2 in a bile duct ligation-induced rat model of liver fibrosis].
    Liu YC; Gu XH; Zhang YD; Chen LB; Tang HM
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):363-6. PubMed ID: 24025138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dynamic changes of alpha-AR, beta1-AR and beta2-AR expression during hepatic fibrogenesis].
    Liu N; Zhang XL; Liang CD; Yao DM; Liu L; Zhao DQ; Tian XP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):653-6. PubMed ID: 19785950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of biliary anastomosis on recovery from secondary biliary cirrhosis.
    dos Santos JS; Kemp R; de Andrade MF; Neder L
    Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1039-50. PubMed ID: 22647740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical study of fibrosis in the rat liver in biliary obstruction.
    Koyama K; Muto I; Yamauchi H; Takagi Y; Anezaki T
    Tohoku J Exp Med; 1975 Jun; 116(2):161-72. PubMed ID: 1154383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular Na+/H+ exchange is activated at transcriptional and posttranscriptional levels in rat biliary cirrhosis.
    Elsing C; Reichen J; Marti U; Renner EL
    Gastroenterology; 1994 Aug; 107(2):468-78. PubMed ID: 8039624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered biosynthesis of gangliosides in developing biliary cirrhosis in the rat.
    Senn HJ; Geiser T; Fitzke E; Baumgartner U; Schölmerich J; Gerok W
    J Hepatol; 1991 Sep; 13(2):152-60. PubMed ID: 1744419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple hepatic functions of endothelin-1: physiopathological relevance.
    Mallat A; Lotersztajn S
    J Hepatol; 1996 Sep; 25(3):405-13. PubMed ID: 8895023
    [No Abstract]   [Full Text] [Related]  

  • 34. Endothelial cell transformation in primary biliary cirrhosis: a morphological and biochemical study.
    Babbs C; Haboubi NY; Mellor JM; Smith A; Rowan BP; Warnes TW
    Hepatology; 1990 May; 11(5):723-9. PubMed ID: 2347545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin-1 and tumour development.
    Asham EH; Loizidou M; Taylor I
    Eur J Surg Oncol; 1998 Feb; 24(1):57-60. PubMed ID: 9542519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.
    Kotani K; Kawada N
    Gut Liver; 2024 Jan; 18(1):27-39. PubMed ID: 37842727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology of portal hypertension.
    McConnell M; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):11-23. PubMed ID: 29075990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
    Thirunavukkarasu C; Yang Y; Subbotin VM; Harvey SA; Fung J; Gandhi CR
    Gut; 2004 Jul; 53(7):1010-9. PubMed ID: 15194653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the hepatic endothelin system in advanced biliary fibrosis in rats.
    Rothermund L; Leggewie S; Schwarz A; Thöne-Reinecke C; Cho JJ; Bauer C; Paul M; Neumayer HH; Schuppan D; Hocher B
    Clin Chem Lab Med; 2000 Jun; 38(6):507-12. PubMed ID: 10987198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the hepatic endothelin-system in rats with biliary liver fibrosis.
    Rothermund L; Cho JJ; Leggewie S; Schwarz A; Bauer C; Paul M; Neumayer HH; Schuppan D; Hocher B
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S270-3. PubMed ID: 11078396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.